Key statistics
As of last trade Crinetics Pharmaceuticals Inc (6Z4:DEU) traded at 53.50, -8.55% below its 52-week high of 58.50, set on Nov 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 53.00 |
---|---|
High | 54.50 |
Low | 53.00 |
Bid | 53.00 |
Offer | 53.50 |
Previous close | 53.50 |
Average volume | 58.80 |
---|---|
Shares outstanding | 92.74m |
Free float | 90.35m |
P/E (TTM) | -- |
Market cap | 5.20bn USD |
EPS (TTM) | -3.72 USD |
Data delayed at least 15 minutes, as of Nov 25 2024.
More ▼
Announcements
- Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
- UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
- Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting
- Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
- Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
- Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
- Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
- Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
More ▼